Unpacking the Latest Options Trading Trends in IonQ
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in IonQ’s options at specified strike prices. » Read more about: Unpacking the Latest Options Trading Trends in IonQ »
Read MoreUnpacking the Latest Options Trading Trends in Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly’s key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and …
» Read more about: Unpacking the Latest Options Trading Trends in Eli Lilly »
Read MoreSix officials of IndusInd Bank under investigation for insider trading: Report
SEBI examining the timing of trades by these six officials to ascertain whether the sales violated regulations, the report said …
» Read more about: Six officials of IndusInd Bank under investigation for insider trading: Report »
Read MoreWalmart stock slips as Trump takes aim at retail giant over tariff-fueled price hikes
A scolding from President Trump comes with a side of stock-price pressure for Walmart (WMT).
Shares of the retail giant fell around 2% in pre-market trading on Monday following Trump’s weekend social media post, which urged the company not to increase its prices because of tariffs on Chinese imports.
Read MoreApple Rattled As OpenAI Acquires io to Develop AI Devices
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!
AI is eating the world—and the machines behind it are ravenous.
Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy.
» Read more about: Apple Rattled As OpenAI Acquires io to Develop AI Devices »
Read MoreThe Burst
Buffett Sold 100% of His Holdings in These Stocks
» Read more about: Buffett Sold 100% of His Holdings in These Stocks »
Read MoreThe Ivy
Alert: Get Pharma Royalties Plus 58.1% Upside
Investment Alert: Buy Royalty Pharma (RPRX) Under $33/share
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
How would you like a cut of those lucrative pharmaceutical royalties that famously mint money?
» Read more about: Alert: Get Pharma Royalties Plus 58.1% Upside »
Read More